[IMNM] Biotech Absurdity
Low float stocks are prone to major moves on nominal volume. Unfortunately in both directions. Here’s what’s going on with IMNM…
Low float stocks are prone to major moves on nominal volume. Unfortunately in both directions. Here’s what’s going on with IMNM…
The latest data out of Immunome underscores the superiority of its approach and demonstrates why the stock could be the next high-flying Novavax (NVAX)
The latest data out of Immunome underscores the superiority of its approach and demonstrates why the stock could be the next high-flying Novavax (NVAX)
The latest data out of Immunome underscores the superiority of its approach and adds urgency to the opportunity. Here’s why…